Synthesis and PTP1B Inhibitory Activity of (E)-1-Substitutedphenyl-3-(4-((E)-(2-(4-phenylthiazol-2-yl)hydrazono)methyl)pheny1)-prop-2-en-1-ones

被引:6
作者
Sun, Liangpeng [1 ]
Jiang, Zhe [2 ]
Gao, Lixin [3 ]
Liu, Xiaofang [1 ]
Quan, Yingchun [1 ]
Zheng, Guanghao [1 ]
Li, Jia [3 ]
Piao, Huri [1 ]
机构
[1] Yanbian Univ, Coll Pharm, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji 133002, Peoples R China
[2] Yanbian Univ Hosp, Yanji 133002, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
PTP1B inhibitor; chalcone; carboxaldehyde hydrazone; thiazole; TYROSINE-PHOSPHATASE; 1B; STRUCTURE-BASED DESIGN; CHALCONE DERIVATIVES; ANTIBACTERIAL; SPECIFICITY; DISCOVERY; POTENT; ACID;
D O I
10.6023/cjoc201212012
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Protein tyrosine phosphatase 1B (PTP1B) has recently been identified as new drug target for type II diabetes and obesity due to that it is a negative regulator of the insulin and leptin-signaling pathway. In order to find new nonphosphonate-based pTyr mimetics, a series of novel (E)-1-phenyl-3-(44(E)-(2-(4-phenyl-thiazol-2-yl)hydrazono)methyl)phenyl)-prop-2-en-1-one (4a similar to 4n) were designed, synthesized, and evaluated for their PTP1B inhibitory activity. The results demonstrated that all compounds presented potent inhibitory activities against PTP1B, among which compound 4h exhibited most potent with IC50 value of (2.57 +/- 0.50) mu mol-L-1.
引用
收藏
页码:1496 / 1502
页数:7
相关论文
共 30 条
[1]  
[Anonymous], 2008, ANN ICRP
[2]   Structure-based design of protein tyrosine phosphatase-1B inhibitors [J].
Black, E ;
Breed, J ;
Breeze, AL ;
Embrey, K ;
Garcia, R ;
Gero, TW ;
Godfrey, L ;
Kenny, PW ;
Morley, AD ;
Minshull, CA ;
Pannifer, AD ;
Read, J ;
Rees, A ;
Russell, DJ ;
Toader, D ;
Tucker, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (10) :2503-2507
[3]   Investigations on the 2-thiazolylhydrazyne scaffold: Synthesis and molecular modeling of selective human monoamine oxidase inhibitors [J].
Chimenti, Franco ;
Bolasco, Adriana ;
Secci, Daniela ;
Chimenti, Paola ;
Granese, Arianna ;
Carradori, Simone ;
Yanez, Matilde ;
Orallo, Francisco ;
Ortuso, Francesco ;
Alcaro, Stefano .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (15) :5715-5723
[4]   Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the Heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic [J].
Combs, Andrew P. ;
Zhu, Wenyu ;
Crawley, Matthew L. ;
Glass, Brian ;
Polam, Padmaja ;
Sparks, Richard B. ;
Modi, Dilip ;
Takvorian, Amy ;
McLaughlin, Erin ;
Yue, Eddy W. ;
Wasserman, Zelda ;
Bower, Michael ;
Wei, Min ;
Rupar, Mark ;
Ala, Paul J. ;
Reid, Brian M. ;
Ellis, Dawn ;
Gonneville, Lucie ;
Emm, Thomas ;
Taylor, Nancy ;
Yeleswaram, Swamy ;
Li, Yanlong ;
Wynn, Richard ;
Burn, Timothy C. ;
Hollis, Gregory ;
Liu, Phillip C. C. ;
Metcalf, Brian .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (13) :3774-3789
[5]   Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer [J].
Combs, Andrew P. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (06) :2333-2344
[6]   Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics [J].
Combs, AP ;
Yue, EW ;
Bower, M ;
Ala, PJ ;
Wayland, B ;
Douty, B ;
Takvorian, A ;
Polam, P ;
Wasserman, Z ;
Zhu, WY ;
Crawley, ML ;
Pruitt, J ;
Sparks, R ;
Glass, B ;
Modi, D ;
McLaughlin, E ;
Bostrom, L ;
Li, M ;
Galya, L ;
Blom, K ;
Hillman, M ;
Gonneville, L ;
Reid, BG ;
Wei, M ;
Becker-Pasha, M ;
Klabe, R ;
Huber, R ;
Li, YL ;
Hollis, G ;
Burn, TC ;
Wynn, R ;
Liu, P ;
Metcalf, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) :6544-6548
[7]   Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles [J].
Dawood, Kamal M. ;
Abdel-Gawad, Hassan ;
Rageb, Eman A. ;
Ellithey, Mohey ;
Mohamed, Harlan A. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (11) :3672-3680
[8]   Synthesis of some new 2,4-disubstituted thiazoles as possible antibacterial and driti-inflammatory agents [J].
Holla, BS ;
Malini, KV ;
Rao, BS ;
Sarojini, BK ;
Kumari, NS .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (03) :313-318
[9]   Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: Synthesis, biological evaluation, and structure-activity relationships [J].
Horiuchi, Takao ;
Chiba, Jun ;
Uoto, Kouichi ;
Soga, Tsunehiko .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) :305-308
[10]   Signaling - 2000 and beyond [J].
Hunter, T .
CELL, 2000, 100 (01) :113-127